Potential Stem Cell Treatment Developed for Lung Disorders

August 4, 2017

(Genetic Engineering & Biotechnology News) – A team of investigators from the University of North Carolina School of Medicine (UNCSM) and North Carolina State University (NCSU) have just released details from a promising study that could potentially offer new stem cell treatment options to patients afflicted with lung conditions such as idiopathic pulmonary fibrosis (IPF), chronic obstructive pulmonary disease (COPD), and cystic fibrosis (CF). Due to the success of this new research, the investigators have been in discussions with the FDA and are preparing an application for an initial clinical trial in patients with IPF.